Expanded Hemodialysis Therapy Market Analysis

  • Report ID: 3372
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Expanded Hemodialysis Therapy Market Segmentation:

Type Segment Analysis

The global expanded hemodialysis therapy market is segmented and analyzed for demand and supply by type into short daily, conventional long-term, and nocturnal. Out of the three types of hemodialysis, the conventional segment is estimated to gain the largest market share of about 42% in the year 2035. The major factor attributed to the growth of the segment is the rising cases of kidney disorders that require dialysis on a regular basis. Also, the rising number of deaths owing to untreated kidney disease is estimated to fuel segment growth. Recent statistics published in 2023 revealed that approximately 1 million people die across the globe owing to untreated kidney failure each year. Also, the various advantages of conventional hemodialysis therapy such as high effectiveness, better results, positive outcomes, and enhanced patient experience are also expected to aid the expand the segment size during the forecast period.

End-user Segment Analysis

The global expanded hemodialysis therapy market is also segmented and analyzed for demand and supply by end-user into hospital, independent dialysis, and home dialysis. Amongst these three segments, the hospital segment is expected to garner a significant share of around 46% in the year 2035 with a notable CAGR value. The major factors attributed to the growing segment size are the rising number of hospitals across the world and the presence of hospitals in every region coupled with rising investments by the government and key players for enhancing the hospital infrastructure. For instance, there were over 8,000 hospitals in Japan as of 2020. Korea, by contrast, had about 4,000 hospitals. In addition, there were more than 6000 hospitals in the United States. Furthermore, the rising preference of the global population to get treated in effective hospital settings and the availability of advanced medical devices and trained medical professionals to perform dialysis, and expanded hemodialysis therapy are also estimated to drive segment growth during the forecast period.

Our in-depth analysis of the global market includes the following segments:

       By Product

  • Machines
  • Dialyzers
  • Concentrates
  • Dialysates
  • Catheters

       By Type

  • Short Daily
  • Conventional Long-Term
  • Nocturnal

       By Application

  • Priced Equipment
  • Service
  • Consumable, Drug

        By End-user

  • Hospital
  • Independent Dialysis
  • Home Dialysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of expanded hemodialysis therapy is evaluated at USD 99.26 billion.

The global expanded hemodialysis therapy market size exceeded USD 95.07 billion in 2025 and is set to expand at a CAGR of over 4.9%, surpassing USD 153.39 billion revenue by 2035.

North America is anticipated to command a 35% share by 2035 in the expanded hemodialysis therapy market, supported by escalating healthcare expenditure, higher disposable incomes, and growing demand for advanced product development.

Key players in the market include B. Braun Melsungen AG, Asahi Kasei Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., Cantel Medical Corp., Satellite Healthcare, Inc., MEDIVATORS, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos